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Abstract
Background: Herbal preparations like STW 5 (Iberogast®)
are widely used drugs in the treatment of dyspepsia and
motility-related disorders of the gastrointestinal tract.
STW 5 is a phytotherapeutic agent consisting of a fixed
mixture of 9 individual plant extracts. The electrophysio-
logical mechanisms of action of STW 5 remain obscure.
Aim: The aim of the present study was to investigate
whether herbal extracts influence electrophysiological
parameters of the small intestine. For this purpose, the
resting membrane potential (RMP) and the slow wave
rhythmicity of smooth muscle cells of mouse small intes-
tine were observed. Methods: Intracellular recordings of
smooth muscle cells of the circular muscle layer of
mouse small intestine were performed using standard
microelectrode techniques. After dissection of the muco-
sa, the small intestine was placed in an organ bath and a
microelectrode was applied on a circular smooth muscle
cell. The RMP and the amplitude of slow waves were
measured in millivolts. Results: The RMP of smooth
muscle cells was –59 B 1.3 mV. This RMP was signifi-
cantly depolarized by STW 5 (9.6 B 1.6 mV); the depolar-
izing effects can be mainly attributed to the constituents
of matricariae flos, angelicae radix and chelidonii herba.
The basal frequency of small intestinal slow waves was
39.5 B 1.4 min–1 and the amplitude was 23.1 B 0.9 mV.
STW 5 significantly reduced the amplitude and frequen-
cy of the slow waves (11.7 B 0.8 mV; 33.5 B 3.4 min–1).
This effect on slow waves represents the sum of the
effects of the 9 phytoextracts. Whereas angelicae radix
and matricariae flos completely blocked slow wave activ-
ity, Iberis amara increased the frequency and amplitude,
chelidonii herba reduced the frequency and amplitude of
the slow waves, mentae piperitae folium reduced the fre-
quency and left amplitude unchanged and liquiritae ra-
dix, carvi fructus and melissae folium had no effects.
Conclusion: Herbal extracts cause changes in smooth
muscle RMP and slow wave rhythmicity, up to reversible
abolition, by blockade of large conductance Ca2+ chan-
nels and other not yet identified mechanisms. In herbal
preparations like STW 5 these effects add up to a total
effect and this study indicates that herbal preparations
which are widely used in dyspepsia and motility-related
disorders have characteristic, reproducible, reversible ef-
fects on small intestinal electrophysiology.
Copyright © 2005 S. Karger AG, Basel
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Introduction
Functional gastrointestinal disorders like functional
dyspepsia and motility-associated disorders like irritable
bowel syndrome (IBS) are often treated symptomatically
employing herbal extracts. Among these STW 5 is widely
used in Europe [1–5].
STW 5 is a fixed combination of ethanolic extracts of 9
different herbal constituents with a final ethanol concen-
tration of 31%. The 9 individual herbal extracts are from
Iberis amara (15%), angelicae radix (10%), carvi fructus
(10%), cardui mariae fructus (10%), chelidonii herba
(10%), liquiritae radix (10%), matricariae flos (20%), me-
lissa folium (10%) and menthae piperitae folium (5%)
[6].
The pathophysiological concepts of functional disor-
ders of the intestine notably include motility disturbances
and/or acid production as underlying mechanisms. Hy-
persensitivity of the gut and the autonomic nervous sys-
tem were suggested as possible additional mechanisms
underlying some of the functional disorders. This means
that minimal disturbances of physiological processes may
cause exaggerated sensations within the gastrointestinal
tract.
Small intestine motility is regulated by a number of cir-
cuits including the peristaltic reflex, migrating motor
complexes and slow wave rhythmicity generated by the
interstitial cells of Cajal (ICC). Among these, slow waves
generated by the ICC are the electrophysiological basis of
peristaltic smooth muscle contractions [7, 8]. Smooth
muscle spikes initiated in response to slow waves appear
to propagate through the smooth muscle layer and are
often the first step in the excitation coupling mechanism
leading to contraction [9–12]. The smooth muscle cell
itself appears to act chiefly as recipient of the slow wave,
which it transforms into patterns of contraction [13, 14].
The coupling of ICC and smooth muscle cells is strongly
believed to occur via gap junctions. Morphological evi-
dence for this motion has been provided by electron
microscopy but due to the lack of highly selective gap
junction blockers, final functional evidence is still missing
[15–18]. Though membrane potentials and slow waves
can be modulated by the known excitatory and inhibitory
neurotransmitters, none of the established neurotransmit-
ters can reversibly abolish slow wave activity [9, 19, 20].
To date little if anything is known on the possible
effects of herbal extracts or herbal preparations like STW
5 on intestinal motility and intestinal electrophysiology,
though they have been used for decades with symptomat-
ic benefit in patients with functional dyspepsia and IBS.
Therefore the aim of this investigation was to evaluate the
possible effects of different herbal preparations on the
small intestine by recording membrane potentials of cir-
cular smooth muscle cells and describe changes in resting
membrane potentials (RMP) and intestinal slow wave
rhythmicity.
Materials and Methods
Tissue Preparation for Electrophysiological Experiments
Eight- to ten-week-old male mice BALB/C were anesthetized with
sodium pentobarbital and sacrificed by cervical dislocation in accor-
dance with the recommendations of the government of the state of
Bavaria, Germany. The complete small bowel was removed and
placed into oxygenated Krebs solution of the following composition
(mM ): NaCl 120.35; KCl 5.9; MgCl2, 2.5; NaH2PO4 1.2; NaHCO3
15.5; CaCl2 2.5; glucose 11.5, pH 7.4. The small intestine was opened
along the mesenteric border, cleaned of remaining fecal matter and
pinned out in a Sylgard-lined (Dow Corning Corp.; Midland, Mich.,
USA) dissecting dish containing oxygenated Krebs solution. The
proximal small intestine was separated and the mucosa and submu-
cosa were removed, resulting in sheets of tissue consisting of circular
and longitudinal muscle layers, together with the attached myenteric
plexus.
Intracellular Electrical Recording
Intracellular electrical recordings were performed as described
recently for mouse colon [21, 22]. Sheets of muscle were pinned to
the Sylgard-based electrophysiological chamber using approximately
150–200 micropins (15–25 Ìm in thickness) made of wolfram wire;
the circular muscle layer was uppermost. The chamber was perfused
(5 ml/min–1; Kwik Pump, World Precision Instruments; Sarasota,
Fla., USA) with prewarmed (37°C) oxygenated (95% O2-5% CO2)
Krebs solution. Tissues were allowed to equilibrate for 90–120 min
before the experiments were started. Nifedipine (1 ÌM ) was present
throughout all experiments unless otherwise stated. Capillary glass
microelectrodes (borosilicate glass capillaries, 1.0 mm outer diame-
ter ! 0.58 mm inner diameter, Clark Electromedical Instruments;
Edenbridge, UK) were made using a microelectrode puller (Model
P-97, 3 mm wide filament, Sutter Instruments; Novato, Calif., USA),
filled with KCl (3 M ) and had resistances in the range of 80–
120 Mø. After the equilibration period, a circular smooth muscle
cell was impaled and the membrane potential was recorded against a
‘ground’ Ag-AgCl electrode placed in the bath medium. Then the
tested drugs were added in the perfusate of the organ bath in increas-
ing concentrations. Electrical events were amplified (DUO 733
microelectrode amplifier, World Precision Instruments; Sarasota,
Fla., USA) and digitalized with an analogue-to-digital converter
(SCB 68 interface, National Instruments; Austin, Tex., USA). Per-
manent recordings of membrane potentials were made on a personal
computer running the LABVIEW 5.0 program (National Instru-
ments; Austin, Tex., USA).
Data Presentation and Statistical Analysis
RMPs (mV) and slow wave activity (frequency/amplitude) were
recorded. The amplitudes were measured in millivolts as compared
to the RMP.
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All data are given as mean B standard error of the mean; n indi-
cates the number of independent observations in intracellular record-
ings from different animals. Statistical differences between the treat-
ment groups were tested using a commercial statistical package (Sig-
maStat, Jandel Scientific; San Rafael, Calif., USA) using the paired
or unpaired Student t test as appropriate, followed by Bonferroni
post hoc testing. A probability of less than 5% that the null hypothe-
sis is false was considered to be significant.
Drugs
The drugs used were: nifedipine, tetrodotoxin (TTX), guanethi-
dine, atropine, hexamethonium, ethanol (all: Sigma-Aldrich; Tauf-
kirchen, Germany); herbal preparations: STW 5 (Iberogast®), STW 7
(STW 5 without Iberis amara); herbal extracts: I. amara, angelicae
radix, carvi fructus, cardui mariae fructus, chelidonii herba, liquiri-
tae radix, matricariae flos, melissae folium, mentae piperitae folium
(all: Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany).
The herbal extracts were either used as lyophilized extracts or dis-
solved in ethanol, as indicated in the Methods and Results sections.
The individual solutions were used at the same concentrations as in
STW 5.
The drugs were freshly dissolved in saline on the day of the exper-
iment and further diluted in Krebs solution to organ bath concentra-
tions. Drugs were added to the perfusate, and experiments were con-
trolled for the effects of the drug solvents (ethanol).
Results
Recording of Circular Smooth Muscle Membrane
Potential and Slow Wave Rhythmicity
In the absence of drugs, circular smooth muscle cells of
the small intestine displayed a stable RMP –59 B 1.3 mV
and a stable slow wave activity with an amplitude of 23.1
B 0.9 mV and a frequency of 39.5 B 1.4 min–1 (n = 15).
Additionally, an irregular spiking activity could be seen
following slow wave rhythmicity. Nifedipine (10 ÌM),
which blocks large conductance Ca2+ channels did not sig-
nificantly alter RMP or slow wave activity, whereas spik-
ing activity following slow wave depolarization was abol-
ished. Neither the neuronal blocker TTX (3 ÌM) nor atro-
pine (1 ÌM) or guanethidine (1 ÌM) had an influence on
RMP, slow wave rhythmicity or amplitude and spiking
activity (data not shown).
Influence of STW 5 on RMP and Slow Wave Activity
STW 5 used as ethanolic solution dose-dependently
depolarized RMP [1:1,000: +1.5 B 1.2 mV; 1:100: +3.6
B 0.7 mV; 1:50: +6.8 B 0.6 mV (p ! 0.05); 1:10: +17.0 B
0.4 mV (p ! 0.05); n = 7] and reduced slow wave frequen-
cy [control: 39.5 B 1.4 min–1; 1:1,000: 43.0 B 1.0 min–1;
1:100: 37.8 B 0.9 min–1; 1:50: 22.9 B 1.5 min–1 (p ! 0.05
and p ! 0.05 vs. ethanol effect ); 1:10: abolished; n = 7 (p !
0.05 and p ! 0.05 vs. ethanol effect)] and slow wave
Fig. 1. The figure shows an original recording of circular smooth
muscle cell RMP, slow wave activity and spiking activity. STW 5
(ethanolic solution) was added in the chamber perfusate stepwise
every 10 min. Please note the depolarizing effect on RMP and the
depressant effect on slow wave activity until abolition, which is
reversible after removal of STW 5 from the organ bath.
20 mV
60 mV
1:1,000 1:100 1:10 Washout
5 min
STW 5 (ethanol solution)
amplitude [(control: 23.1 B 0.9 mV); 1:1,000: 27.1 B
1.0 mV; 1:100: 18.5 B 3.0 mV (p ! 0.05); 1:50: 6.3 B
1.5 mV (p ! 0.05 and p ! 0.05 vs. ethanol effect); 1:10:
abolished; n = 7, (p ! 0.05; p ! 0.05 vs. ethanol effect)] up
to abolition (fig. 1). The abolition was immediately re-
versible when STW 5 was removed from the organ bath
(fig. 1). The spiking activity following slow waves was
abolished at concentrations higher than 1:100 (fig. 1, 2).
STW 5 used as solution from lyophilized extracts dose-
dependently depolarized RMP [1:1,000: +4.5 B 1.2 mV;
1:100: +6.6 B 1.8 mV; 1:50: +9.6 B 1.6 mV (p ! 0.05);
n = 6] and reduced slow wave frequency [1:1,000: 46.0 B
2.4 min–1; 1:100: 38.8 B 1.9 min–1; 1:50: 33.5 B
3.4 min–1 (p ! 0.05); n = 6] and slow wave amplitude
[1:1,000: 23.5 B 0.5 mV; 1:100: 18.5 B 0.5 mV (p !
0.05); 1:50: 11.7 B 0.8 mV; n = 6] up to abolition (fig. 3).
The abolition was reversible when STW 5 was removed
from the organ bath perfusate. The spiking activity fol-
lowing slow waves was abolished at concentrations higher
than 1:100 (fig. 3).
Influence of Ethanol on RMP and Slow Wave Activity
Ethanol dose-dependently depolarized RMP [1:100:
no change; 1:50: +4.0 B 0.4 mV; 1:10: +12.5 B 0.6 mV
(p ! 0.05); n = 6] and reduced slow wave frequency [1:100:
46.1 B 2.9 min–1; 1:50: 36.8 B 1.9 min–1; 1:10: 32.6 B
1.7 min–1 (p ! 0.05); n = 6], and slow wave amplitude
[1:100: no change; 1:50: 16.5 B 2.2 mV; 1:10: 19.2 B
2.8 mV (p ! 0.05); n = 6]. The effect was immediately
reversible, when ethanol was removed from the organ
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Fig. 2. a Depressant effect of STW 5 on spiking activity in response to slow waves for the 1:100 concentration and the
depressant effect on slow wave activity up to abolition for the 1:10 concentration of STW 5. b Recordings of the same
patterns in the presence of the same concentrations of ethanol solution as in the STW 5 solution. Please note that
equal ethanol concentrations do not change the spiking activity at 1:100 whereas at 1:10 ethanol does influence RMP



















bath. However, the effects of ethanol were significantly
lower than those of the ethanol-diluted herbal extract
STW 5.
Influence of STW 7 on RMP and Slow Wave Activity
STW 7 used as ethanolic solution dose-dependently
depolarized RMP [1:1,000: +7.5 B 1.9 mV; 1:100: +10.6
B 2.8 mV (p ! 0.05 and p ! 0.05 vs. ethanol effect); 1:50:
+16.8 B 3.6 mV (p ! 0.05 and p ! 0.05 vs. ethanol effect);
n = 6] and reduced slow wave frequency [1:1,000: 47.0 B
2.6 min–1; 1:100: 36.8 B 1.9 min–1; 1:50: 25.9 B
2.7 min–1 (p ! 0.05 and p ! 0.05 vs. ethanol effect); n = 6]
and slow wave amplitude [1:1,000: 29.5 B 0.8 mV; 1:100:
17.5 B 1.2 mV (p ! 0.05 and p ! 0.05 vs. ethanol effect);
1:50: 7.2 B 1.8 mV (p ! 0.05 and p ! 0.05 vs. ethanol
Fig. 3. Depressant effect of STW 5 used as lyophilized extract on
smooth muscular spiking activity at the concentraction of 1:100 and
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Fig. 4. Changes in slow wave activity and resting membrane potential for STW 5 and each individual herbal extract.








20 mV 20 mV 20 mV 20 mV
60 mV 60 mV 60 mV 60 mV
5 min 5 min 5 min 5 min
Iberis amara (STW 6) Mentae piperitae (STW 5K-II) Matricariae flos (STW 5K-III) Liquiritae radix (STW 5K-IV)
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5 min 5 min
Carvi fructus (STW 5K-VI) Cardui mariae (STW 5K-VII) Melissa folium (STW 5K-VIII) Chelidoni herba (STW 5K-IX)
20 mV 20 mV 20 mV 20 mV
60 mV 60 mV 60 mV 60 mV
10 s 10 s 10 s 10 s
Table 1. Effects of the herbal preparation
STW 5 and the individual herbal extracts on







Control –59B1.3 23.1B0.9 39.5B1.4
STW 5 +9.6B1.6* 11.7B0.8* 33.5B3.4*
I. amara (STW 6) no change 30.8B2.1* 50.2B2.9*
Mentae piperitae folium (STW 5K-II) no change 15.8B1.8* NC
Matricariae flos (STW 5K-III) +19.3B1.9* abolished abolished
Liquiritae radix (STW 5-IV) no change no change no change
Angelicae radix (STW 5K-V) +12.5B1.8* abolished abolished
Carvi fructus (STW 5K-VI) no change no change no change
Cardui mariae fructus (STW 5K-VII) –5.0B0.9 25.8B1.2 13.3B2.3*
Melissae folium (STW 5K-VIII) +5.1B1.6 20.2B1.5 40.3B2.0 
Chelidonii herba (STW 5K-IX) +12.2B2.0* 11.8B1.7* 18.7B1.9*
The herbal extracts used were ethanol-free lyophilized extracts diluted in KRS to the final
bath concentration of 1:50. * p ! 0.05 vs. untreated control.
effect); n = 6]. The effect was immediately reversible,
when STW 7 was removed from the organ bath.
Influence of the Individual Herbal Extracts on RMP
and Slow Wave Activity
The individual herbal extracts used at the same con-
centration as in the herbal preparation STW 5 are still
mixtures of various substances. They all had individual or
no effects on RMP, slow wave activity and slow wave
amplitude (fig. 4). The values of the effects of the individ-
ual lyophilized (ethanol free) herbal extracts added 1:50
into the organ bath are given in table 1.
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Discussion
Treatment of functional dyspepsia and IBS is ham-
pered by the lack of an accepted pathophysiological etiol-
ogy. Presently various drugs influencing motility (e.g.
spasmolytics, dopaminergics and serotoninergics) or hy-
persensitivity (e.g. antidepressants and serotoninergics) as
well as herbal extracts are used. They all alleviate the
patients’ symptoms. Though clinical studies show that
herbal extracts like STW 5 are potent antidyspeptic agents
[1–5], little is known on their potential underlying mecha-
nisms, notably on a possible regulation of gastrointestinal
electrophysiological parameters.
Our data clearly show that STW 5 dose-dependently
depolarized RMP of small intestinal smooth muscle cells.
No individual herbal extract caused hyperpolarization,
whereas various individual extracts caused depolariza-
tion. This depolarization influences smooth muscle excit-
ability and since the effects of the extracts are reversible,
these effects are suggested to be nontoxic.
The effects of the herbal extracts on slow wave ampli-
tude and rhythmicity are more interesting. The slow
waves are known to be generated by the ICC, and maxi-
mum slow wave frequency in turn sets the maximum fre-
quency of contractions and determines the propagation
characteristics of the rhythmic contractions in the intes-
tine [8, 9, 23, 24] and no individual nontoxic drug can
reversibly abolish slow wave rhythmicity. Abolition of
slow waves is reported only in genetically modified mice
missing the ICC [25]. Whereas the regulatory mechanisms
responsible for slow wave generation are still unknown,
frequency seems to be dependent on extracellular Ca2+
content as demonstrated by voltage clamp experiments
[26] and on release of intracellularly stored Ca2+ [27].
Intestinal slow wave activity can be increased by drugs
sensitizing IP3 receptors (inositol 1,4,5,-trisphosphate) in-
volved in the regulation of Ca2+ release from the intracel-
lular stores [28]. Electrical coupling of ICC to smooth
muscle cells is believed to occur via a gap junctional cou-
pling. Due to the absence of specific drugs modulating the
gap junctional functioning, the interpretation of mecha-
nisms modulating slow wave activity remains speculative.
To our knowledge, this is the first report on drugs that
reversibly abolish slow wave activity.
STW 5 potently reduced slow wave amplitude and fre-
quency. This effect is clearly different from the effect of
ethanol in equimolar concentrations. The reduction in
slow waves in our study was also present when STW 5 was
used in an ethanol-free lyophilized application form. As
for the RMP, the different individual herbal extracts had
different effects on the slow waves, ranging from an
increase in amplitude and frequency for I. amara to a
decrease in amplitude and frequency for other extracts.
Some of the herbal extracts, notably liquiritae radix and
carvi fructus extracts caused no significant effect on slow
wave rhythmicity. This multiple mode of action when
combined in the final herbal preparation resulted in a net
depressant effect on slow waves. Though STW 5 and most
of the single extracts caused depressant effects on slow
waves, the I. amara extract augmented the slow waves,
again pointing to a multiple mode of action of the herbal
preparation STW 5 due to the combination of different
herbal extracts. This multiple mode of action might be a
reason why STW 5 exerts a beneficial effect on symptoms
in functional disorders where more than one pathome-
chanism might come into play. The multiple mode of
action is further stressed by the finding that STW 5 at low
concentrations shows a trend towards increasing slow
wave frequency and amplitude; thereafter, slow waves are
depressed at higher concentrations.
We also investigated STW 7, which does not include
I. amara extract, but whose composition is otherwise the
same, in order to find out whether the removal of this
extract, which augments the amplitude and frequency of
slow waves, influences the global effects of the herbal
preparation. Though we found a trend towards different
effects of STW 5 and STW 7 in the lower concentrations,
this difference did not reach statistical significance.
In addition to the reported effects on slow wave rhyth-
micity, STW 5 also abolished the spiking activity of
smooth muscle cells in response to slow wave rhythmicity.
This spiking activity following slow wave activity is the
known first step in the excitation coupling mechanism
leading to contraction of smooth muscle [13, 14]. In agree-
ment with others, the spiking activity in our experiments
could be abolished by nifedipine, demonstrating its de-
pendence on Ca2+ channel function. Since STW 5 abol-
ishes this spiking activity, it may be suggested that smooth
muscle contractility is reduced by mechanisms influenc-
ing slow waves and mechanisms regulating smooth mus-
cle excitability. Which individual component of STW 5
influences muscular excitability, most likely by blockade
of large conductance Ca2+ channels, will have to be
answered by future investigations.
Besides the effects on motility parameters reported
here, extracts of chelidonii herba and matricariae flos
show high affinity binding on 5-HT4 receptors, but func-
tional data on the effects on gastrointestinal motility are
still missing [29]. The binding on 5-HT4 receptors gives
further evidence on possible mechanisms influencing gas-
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trointestinal motility since agonists on the 5-HT4 receptor
are accepted potent prokinetics [30]. Interestingly, high
affinity receptor binding of the extracts of chelidonii her-
ba on the muscarinic M3 receptor was proven. This recep-
tor is involved in cholinergic stimulation of smooth mus-
cle cells [29].
Effects of STW 5 or its constituents on motility have
rarely been characterized. In guinea pig gastric fundus
and corpus smooth muscle strips, STW 5 potently re-
duced basal tone whereas the tone of antral smooth mus-
cle strips remained unchanged. In contrast, phasic activi-
ty and amplitude of antral contractions were increased
[31]. This may indicate that gastric adaptive relaxation of
fundus and corpus is enhanced and antral activity is
increased, both desired effects in patients with dyspepsia
and impaired gastric emptying. The individual constitu-
ents showed different effects on the observed parameters,
suggesting that the combination of the different extracts
in STW 5 is essential for the balanced additive effect [31].
In agreement with our findings, the individual extracts
caused different effects which resulted in an additive
effect for the herbal preparation STW 5.
Comparable tonic and spasmolytic effects were re-
ported earlier for guinea pig small intestine. Cholinergic-
mediated contractions are decreased by STW 5 whereas
the extract of I. amara alone has a tonic effect on smooth
muscle [32]. In addition, I. amara extract stimulates phas-
ic basal activity of small intestine, similarly to the stimu-
latory effect on antral phasic activity observed with I.
amara extract. Moreover quantitative comparison indi-
cates that the spasmolytic potency of STW 5 (10 ml/l) is
higher than that of papaverin (10 mg/l) [32]. Interestingly,
STW 5 has a tonic action under basal conditions and a
relaxant action in precontracted smooth muscle [32]. This
multiple mode of action might be attributed to the differ-
ent individual constituents and their individual effects on
motility patterns [33] and its balanced mode of action
might be the key to the proven therapeutic benefit of STW
5 in the functional diseases in which it is used.
Further investigation on the main constituents of the
individual herbal extracts (e.g. silibinin, chelidonin, pro-
topin, glycyrrhicinic acid) showed individual effects on
smooth muscle preparations, but none of these individual
substances exerted the effects of the STW 5 herbal prepa-
ration [33].
Besides its effects on motility parameters, STW 5 also
reduced neuronal activity following small intestinal stim-
ulation by pharmacological (5-HT, bradykinin) or me-
chanical intraluminal stimuli, indicating that the sensitiv-
ity of the small intestine was reduced [34]. The effects on
sensitivity include chemo- and mechano-sensitive affer-
ent neurons and the chemo-sensitive neurons include
vagal afferent neurons (5-HT sensitive) and spinal affer-
ent neurons (bradykinin-sensitive) [34]. The effects on
mechano-sensitive neurons can be observed following low
and high pressure on small intestinal mucosa [34]. Addi-
tionally, there are reports on anti-ulcerative and acid sup-
pressing actions [35], suppression of Helicobacter pylori
growth [36] and antioxidative properties [33, 37]. Espe-
cially the antioxidative effects might partially influence
motility parameters since some neurotransmitters in the
enteric nervous system (e.g. nitric oxide) are influenced by
the presence of free radicals [38].
In summary this investigation shows that herbal ex-
tracts modulate RMP as well as slow wave amplitude and
rhythmicity of mouse small intestinal circular smooth
muscle which are the electrophysiological basis of smooth
muscle contractility and motility phenomena of the intes-
tine. The effects of the individual herbal extracts used in
the herbal preparation STW 5 add up to a total effect and
the addition of individual effects might be the reason why
STW 5 is helpful in relieving functional gastrointestinal
symptoms in disorders of various origins and presently
unknown pathophysiologies.
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